Anti-PD1 antibody [EPR26302-8]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Anti-PD1 antibody [EPR26302-8] is a Rabbit Monoclonal antibody that is used in PD1 Flow Cytometry, ICC/IF, IP, Western Blot. Suitable for Mouse samples.
PD1, or programmed cell death protein 1 or CD279 is a 50-55 kD glycoprotein belonging to the CD28 family of the Ig superfamily. PD-1 is expressed on activated splenic T and B cells and thymocytes. It is induced on activated myeloid cells as well. PD-1 is involved in lymphocyte clonal selection and peripheral tolerance through binding PD-L1 and PD-L2. It is an immune checkpoint receptor that plays a critical role in down-regulating the immune system and promoting self-tolerance by inhibiting T cell inflammatory activity. In cancer, PD1 is often exploited by tumor cells to evade immune detection and destruction, leading to tumor growth and progression. Blocking PD1 with specific inhibitors can restore T cell activity and enhance anti-tumor immunity, making it a significant target in cancer immunotherapy.
View Alternative Names
CD279, Pd1, Pdcd1, Programmed cell death protein 1, Protein PD-1, mPD-1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PD1 antibody [EPR26302-8] (AB300425)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized EL4 (mouse lymphoma T lymphocyte) cells labelling PD-1 with ab300425 at 1/100 (4.47 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing membranous staining in EL4 cell line. Negative control : CTLL-2 (PMID : 34580467). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-PD1 antibody [EPR26302-8] (AB300425)
Flow cytometric analysis of CTLL-2 (mouse T lymphocyte, Left) / EL4 (mouse lymphoma T lymphocyte, Right) cells labelling PD-1 with ab300425 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.Negative control : CTLL-2 (PMID : 1396582).
- IP
Supplier Data
Immunoprecipitation - Anti-PD1 antibody [EPR26302-8] (AB300425)
PD-1 was immunoprecipitated from 0.35 mg EL4 (mouse lymphoma T lymphocyte), whole cell lysate 10 ug with ab300425 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab300425 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : EL4 (mouse lymphoma T lymphocyte), whole cell lysate 10 ug Lane 2 : ab300425 IP in EL4 whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab300425 in EL4 whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 3 minutes
Lane 1:
Immunoprecipitation - Anti-PD1 antibody [EPR26302-8] (ab300425) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-PD1 antibody [EPR26302-8] (ab300425) at 1/1000 dilution
All lanes:
EL4 whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 3min
Related conjugates and formulations (4)
-
Anti-PD1 antibody [EPR26302-8] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PD1 antibody [EPR26302-8]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PD-1 antibody [EPR26302-8]
-
578 PE
PE Anti-PD1 antibody [EPR26302-8]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD1 serves as an inhibitory receptor acting as a checkpoint in the immune system. It becomes part of an immune-suppressive complex when it binds with its ligands PD-L1 or PD-L2 which are expressed on various cell types including some tumor cells. This interaction suppresses the proliferation of T cells and cytokine production contributing to immune homeostasis. By controlling T cell activity PD1 limits autoimmunity but can also reduce the immune system's capability to attack cancer cells.
Pathways
PD1 functions in the immune checkpoint pathway a critical regulatory circuit in immune regulation. The engagement of PD1 with its ligands initiates a cascade that inhibits the function and proliferation of T cells through downstream SHP-2 phosphatase activity. This pathway frequently involves other regulatory proteins like CTLA-4 and is an important mechanism by which the body modulates immune responses. Related pathways often intersect with those involving T cell receptor signaling and contribute to the overall modulation of immune activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:519 PubMed40671009
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:246 PubMed40437612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com